NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit
Cleveland, Ohio--(Newsfile Corp. - December 1, 2023) - NovAccess Global Inc. (OTCQB: XSNX) announced today it will be presenting at the December 7th, 2023 virtual Investor Summit.
Event: | December 7th Investor Summit | |
Presentation: | December 7th, 2023 @ 1:30 PM ET | |
Location: | https://us06web.zoom.us/webinar/register/WN_ps0tLsybTUyu5q9_J_OXYA |
1x1s will be available for qualified investors
The conference is completely complimentary to qualified investors
About NovAccess Global
NovAccess Global is a preclinical, IND-ready biomedical company accelerating novel cancer diagnostics and therapeutics. Our goal is to discover, develop and bring to market novel and innovative medicine and medical devices to improve the quality of care for cancer and neurological patients.
TLR-AD1 is designed to activate anti-tumor immune responses against brain tumors using immune-activating dendritic cells combined with the patient's own tumor proteins. The resulting dendritic cell vaccine is matured with a proprietary combination of Toll-like receptor adjuvants to enhance the immune-activating potency of the therapy. In 2022, the FDA granted Orphan Drug designation to TRL-AD1 for the treatment of brain cancers. The technology is currently at the pre-IND stage of research and development. For more information, please visit novaccessglobal.com.
Follow us on social media and stay up to date on all of our developments:
https://www.youtube.com/@novaccess
https://www.facebook.com/novaccessglobal
https://www.linkedin.com/company/64892686
https://twitter.com/novaccessglobal
About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Investor Summit will take place virtually, featuring micro-cap companies and institutional, family office, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Technology, Financial, Healthcare, Industrials, Materials, Real Estate. Contact: info@investorsummitgroup.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/189561
